Award
National Cancer Institute 5R44CA285041-03
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
Recipient
Not specified
Award Amount
$1,009,228.00
Ceiling
$1,009,228.00
Awarded
August 14, 2025
Identifier
5R44CA285041-03
Award for developing a blood test to monitor immunotherapy response in lung cancer patients using epigenetic features in cell-free DNA, funded by the National Cancer Institute.
Description
This project involves developing a blood test to monitor immunotherapy response in lung cancer patients using epigenetic features in cell-free DNA.